Showing results (191-200 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|April 13, 2019
Assessing noninferiority: Evaluating efficacy of a new treatment without complete dataPing Gao, Katherine Odem-DavisPharmaceutical Statistics|April 13, 2019
Equilibrium, affinity, dissociation constants, IC5O: Facts and fantasiesJacques Barbet, Sandrine Huclier-MarkaiPharmaceutical Statistics|October 16, 2018
Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritisClaire L Smith, Yan Jin, Eyas Raddad, et al.Pharmaceutical Statistics|February 1, 2022
Decision rules for identifying combination therapies in open-entry, randomized controlled platform trialsElias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger-Baldauf, et al.Pharmaceutical Statistics|September 1, 2018
Bayesian detection of potential risk using inference on blinded safety dataSaurabh Mukhopadhyay, Brian Waterhouse, Alan HartfordPharmaceutical Statistics|May 23, 2019
The importance of cross-disciplinary scientific engagement in the development of quantitative procedures for aggregate safety assessmentsGreg Ball, Fabio LievanoPharmaceutical Statistics|March 9, 2022
Estimating survival parameters under conditionally independent left truncationArjun SondhiPharmaceutical Statistics|March 31, 2022
A treatment-specific marginal structural Cox model for the effect of treatment discontinuationDana Johnson, Karen Pieper, Shu YangPharmaceutical Statistics|September 22, 2021
A note on confidence intervals for the restricted mean survival time based on transformations in small sample sizeHiroya Hashimoto, Akiko KadaPharmaceutical Statistics|August 29, 2018
Nonparametric response-adaptive randomization for continuous responsesZhongqiang Liu, Feifang Hu, Li-Xin ZhangPageof 119